Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Xilio Therapeutics Inc (XLO)

Xilio Therapeutics Inc (XLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Xilio Therapeutics Transfers Listing to Nasdaq Capital Market Tipranks - Sat Oct 4, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Xilio Therapeutics...

XLO : 9.15 (-0.76%)
Xilio Therapeutics Reports Preliminary Phase 1 Data for XTX301 Showing Improved Tolerability and Completes Private Placement with Gilead Quiver Quantitative, Inc. - Thu Dec 19, 2024

Xilio Therapeutics reports promising Phase 1 data for XTX301 with improved tolerability and completed equity investment from Gilead.Quiver AI SummaryXilio Therapeutics, Inc. announced preliminary Phase...

XLO : 9.15 (-0.76%)
Xilio Therapeutics, Inc. Appoints Caroline Hensley as Chief Legal Officer Quiver Quantitative, Inc. - Mon Dec 16, 2024

Xilio Therapeutics appoints Caroline Hensley as chief legal officer to enhance legal support for tumor-activated immuno-oncology therapies.Quiver AI SummaryXilio Therapeutics, Inc. has appointed Caroline...

XLO : 9.15 (-0.76%)

Barchart Exclusives

Cisco Is Up 46% and Oracle Is Down 25% in 2026. The Better Dividend Buy Might Surprise You. Barchart - Fri Jul 3, 6:00PM CDT
Cisco is up 46% in 2026 while Oracle has slid 25%, and Wall Street sees up to 185% upside for one of them. Here's how the two tech giants compare on value, yield, and dividend growth. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.